In lieu of the aforementioned findings, we hypothesized that omega-3 FAs-mediated miR-1-3p/Notch3/Smad3 axis may regulate sepsis-induced intestinal injury, and accordingly set out to perform a series of experiments to validate our hypothesis, aiming to uncover novel therapeutic targets against sepsis. The gene discussed is NOTCH3; the disease is Sepsis.